Hepatitis B News and Research

Latest Hepatitis B News and Research

Plant-derived virus-like particle vaccines against SARS-CoV-2

In a review published in Biotechnology Letters, the authors discuss plant-derived VLP-based vaccines.

1 Dec 2021

Prevalence of menstrual changes following vaccination against COVID-19

A new study investigates the relationship between COVID-19 vaccination and menstrual cycle disturbances.

26 Nov 2021

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School of Medicine reported that after receiving cancer treatment, the oral administration of direct-acting antivirals (DAA) reduces the risk of tumor progression following recurrence of the liver disease.

25 Nov 2021

Study compares immune responses of patients with and without kidney failure after COVID-19 vaccination

Death rates from COVID-19 are especially high in individuals with kidney failure who are on dialysis, making SARS-CoV-2 vaccination in this population a high priority.

24 Nov 2021

Tobacco mosaic virus nanoparticle-based novel COVID-19 vaccine candidate

Scientists generate a VLP type NP platform made of recombinant viral antigens conjugated with TMV virions.

23 Nov 2021

Liver cancer can be recognized by RNA fragments in saliva and blood

RUDN University doctors examined markers of liver cancer and found that the disease can be recognized by RNA fragments in saliva and blood. The results are published in Oncotarget.

23 Nov 2021

An increase in the half-life of remdesivir for COVID-19 treatment

In this study, researchers analyzed several drug candidates to investigate their efficacy against a broad spectrum of coronaviruses in cell culture studies.

23 Nov 2021

Red blood cell distribution width as a biomarker for COVID-19

A review highlights the prospects and challenges of RDW as a predictive biomarker for viral infections, with a special focus on COVID-19 and hepatitis.

22 Nov 2021

Schools, pediatricians look to make up lost ground on non-covid vaccinations

Melissa Blatzer was determined to get her three children caught up on their routine immunizations on a recent Saturday morning at a walk-in clinic in this Denver suburb. It had been about a year since the kids' last shots, a delay Blatzer chalked up to the pandemic.

18 Nov 2021

Combination treatment improves overall survival for melanoma patients with brain metastases

Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread to the brain, according to Phase II study results published today in The Lancet Oncology by researchers from The University of Texas MD Anderson Cancer Center.

11 Nov 2021

UK's health and social care providers required to ensure workers are fully vaccinated against COVID-19

Health and social care providers in England will be required to ensure workers are fully vaccinated against COVID-19, unless they are exempt, under plans announced by the Health and Social Care Secretary.

9 Nov 2021

The role of T follicular helper cells in the humoral immune response to SARS-CoV-2

The current analysis indicates that cTfh cells react to the spike antigen following vaccination are associated with anti-S protein neutralizing antibodies.

9 Nov 2021

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine and MitoPower LLC were awarded an SBIR (Small Business Innovation Research) grant of up to $6.5 million over five years from the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism.

9 Nov 2021

Hepatitis B News and Research

Latest Hepatitis B News and Research

Plant-derived virus-like particle vaccines against SARS-CoV-2

Prevalence of menstrual changes following vaccination against COVID-19

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

Study compares immune responses of patients with and without kidney failure after COVID-19 vaccination

Tobacco mosaic virus nanoparticle-based novel COVID-19 vaccine candidate

Liver cancer can be recognized by RNA fragments in saliva and blood

An increase in the half-life of remdesivir for COVID-19 treatment

Red blood cell distribution width as a biomarker for COVID-19

Schools, pediatricians look to make up lost ground on non-covid vaccinations

Combination treatment improves overall survival for melanoma patients with brain metastases

UK's health and social care providers required to ensure workers are fully vaccinated against COVID-19

The role of T follicular helper cells in the humoral immune response to SARS-CoV-2

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

Hemin as a potential therapy for COVID-19

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

Murine hepatitis virus as a surrogate for studying SARS-CoV-2 in food processing biofilms

Brooklyn College announces the launch of BCCC-CURE to enhance the lives of cancer patients

End-stage renal disease negatively impacts COVID-19 vaccine response

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

Study analyzes the financial burden of chronic hepatitis C on Ontario patients

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Hepatitis B News and Research

Latest Hepatitis B News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in